Macrogen Management
Management criteria checks 2/4
Macrogen's CEO is Jeong-Sun Seo, appointed in Jan 2025, has a tenure of 1.25 years. total yearly compensation is ₩906.60M, comprised of 99.9% salary and 0.07% bonuses, including company stock and options. directly owns 20.01% of the company’s shares, worth ₩37.21B. The average tenure of the management team and the board of directors is 1.3 years and 1.6 years respectively.
Key information
Jeong-Sun Seo
Chief executive officer
₩906.6m
Total compensation
| CEO salary percentage | 99.93% |
| CEO tenure | 1.3yrs |
| CEO ownership | 20.0% |
| Management average tenure | 1.3yrs |
| Board average tenure | 1.6yrs |
Recent management updates
Recent updates
There May Be Underlying Issues With The Quality Of Macrogen's (KOSDAQ:038290) Earnings
Apr 03
Fewer Investors Than Expected Jumping On Macrogen, Inc. (KOSDAQ:038290)
Dec 22Macrogen's (KOSDAQ:038290) Dividend Will Be ₩300.00
Nov 09Calculating The Intrinsic Value Of Macrogen, Inc. (KOSDAQ:038290)
Mar 19Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement
Nov 13Macrogen, Inc.'s (KOSDAQ:038290) Revenues Are Not Doing Enough For Some Investors
Jul 24Macrogen's (KOSDAQ:038290) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 02Macrogen (KOSDAQ:038290) Has Debt But No Earnings; Should You Worry?
Mar 03Reflecting on Macrogen's (KOSDAQ:038290) Share Price Returns Over The Last Three Years
Jan 09
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2025 | n/a | n/a | ₩2b |
| Sep 30 2025 | n/a | n/a | -₩700m |
| Jun 30 2025 | n/a | n/a | -₩6b |
| Mar 31 2025 | n/a | n/a | -₩8b |
| Dec 31 2024 | ₩907m | ₩906m | -₩8b |
| Sep 30 2024 | n/a | n/a | -₩22b |
| Jun 30 2024 | n/a | n/a | -₩21b |
| Mar 31 2024 | n/a | n/a | -₩20b |
| Dec 31 2023 | ₩907m | ₩906m | -₩17b |
Compensation vs Market: Jeong-Sun's total compensation ($USD616.49K) is about average for companies of similar size in the KR market ($USD515.54K).
Compensation vs Earnings: Jeong-Sun's compensation has been consistent with company performance over the past year.
CEO
Jeong-Sun Seo (73 yo)
Mr. Jeong-Sun Seo serves as Professor in College of Medicine, Seoul National University. He has been Director of LightSpeed Genomics Inc. Mr. Seo serves as the Chairman at Macrogen, Inc. and serves as its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 1.3yrs | ₩906.60m | 20.01% ₩ 37.2b | |
| Chief Executive Officer | no data | no data | 0.10% ₩ 190.4m | |
| CEO & Director | less than a year | no data | no data | |
| Head of Clinical Genome Business Division | 1.3yrs | no data | no data | |
| Head of Personal Genome Business Division | 1.3yrs | no data | no data |
Experienced Management: A038290's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | no data | ₩906.60m | 20.01% ₩ 37.2b | |
| CEO & Director | less than a year | no data | no data | |
| Director | no data | no data | no data | |
| Director | no data | no data | no data | |
| Non-Executive Director | no data | no data | 0.00018% ₩ 334.7k | |
| Director | no data | no data | no data | |
| Independent Outside Director | no data | no data | no data | |
| Independent Outside Director | 3.1yrs | no data | no data | |
| Independent Outside Director | 3.1yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
Experienced Board: A038290's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/27 14:56 |
| End of Day Share Price | 2026/04/27 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Macrogen, Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Song-hyup Han | Daishin Securities Co. Ltd. |
| Sang-Hun Lee | iM Securities |
| Jaehoon Choi | Korea Investment & Securities Co., Ltd. |